Juno Therapeutics, Inc. - FORM S-1/A - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - December 9, 2014

Attached files

file filename
S-1/A - AMENDMENT NO. 2 TO FORM S-1 - Juno Therapeutics, Inc.d772541ds1a.htm
EX-3.1 - FORM OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION - Juno Therapeutics, Inc.d772541dex31.htm
EX-3.2 - FORM OF AMENDED AND RESTATED BYLAWS - Juno Therapeutics, Inc.d772541dex32.htm
EX-1.1 - FORM OF UNDERWRITING AGREEMENT - Juno Therapeutics, Inc.d772541dex11.htm
EX-10.25 - 2014 EMPLOYEE STOCK PURCHASE PLAN - Juno Therapeutics, Inc.d772541dex1025.htm
EX-24.2 - POWER OF ATTORNEY - Juno Therapeutics, Inc.d772541dex242.htm
EX-10.22 - 2014 EQUITY INCENTIVE PLAN - Juno Therapeutics, Inc.d772541dex1022.htm
EX-10.28 - EXECUTIVE INCENTIVE COMPENSATION PLAN - Juno Therapeutics, Inc.d772541dex1028.htm
EX-10.24 - FORM OF STOCK OPTION GRANT NOTICE AND OPTION AGREEMENT - Juno Therapeutics, Inc.d772541dex1024.htm
EX-4.1 - FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT - Juno Therapeutics, Inc.d772541dex41.htm
EX-5.1 - OPINION OF WILSON SONSINI GOODRICH & ROSATI, PROFESSIONAL CORPORATION - Juno Therapeutics, Inc.d772541dex51.htm
EX-4.2 - FORM OF COMMON STOCK CERTIFICATE - Juno Therapeutics, Inc.d772541dex42.htm
EX-10.29 - EXCLUSIVE LICENSE AGREEMENT - Juno Therapeutics, Inc.d772541dex1029.htm
EX-10.23 - FORM OF RESTRICTED STOCK PURCHASE AGREEMENT - Juno Therapeutics, Inc.d772541dex1023.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated September 12, 2014, except as to the last paragraph of Note 2, as to which the date is December 8, 2014, in Amendment No. 2 to the Registration Statement (Form S-1 No. 333-200293) and related Prospectus of Juno Therapeutics, Inc. for the registration of shares of its common stock.

/s/ Ernst & Young LLP

Seattle, Washington

December 8, 2014

Juno Therapeutics, Inc. Reports